GGrantIndex
Sort

46,585 grants matching heart failure

Prospective renal insufficiency cohort evaluation: PRICE

$849,264
Raymond R Townsend · University Of Pennsylvania · U01 · FY2010 · DK

Prospective renal insufficiency cohort evaluation: PRICE

$849,263
Raymond R Townsend · University Of Pennsylvania · U01 · FY2008 · DK

Tailored Drug Titration through Artificial Intelligence

$849,047
Gabriela Voskerician · Optima Integrated Health, Inc. · R44 · FY2017 · HL

Ventricular Dynamics from Surgically Inserted Markers

$848,818
Stanford University · R01 · FY2004 · HL

PET Imaging of Thrombus

$848,663
Peter D Caravan · Massachusetts General Hospital · R01 · FY2020 · HL

ASSOCIATION OF SLEEP DISORDERS WITH CARDIOVASCULAR HEALTH ACROSS ETHNIC GROUPS

$848,491
Susan S Redline · Brigham And Women'S Hospital · R01 · FY2013 · HL

Evaluation of HIV-associated Cardiac Dysfunction in Women

$848,351
Jorge R Kizer · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · HL

Women's Health Study: Continued Follow-up

$848,006
Julie E Buring · Brigham And Women'S Hospital · R01 · FY2010 · CA

First-in-Human Use of an Artificial Lung for Ambulatory Respiratory Support

$847,947
Bartley Perry Griffith · University Of Maryland Baltimore · R01 · FY2016 · HL

Role of UPR transducer Xbp1 in Pancreatic Beta Cell Survival and Function under Metabolic Stress

$847,746
Yingfeng Deng · Beckman Research Institute/City Of Hope · R01 · FY2025 · DK

C-TRIP: Targeted Gene Therapy for the Treatment of Heart Failure (P20)

$847,500
Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · P20 · FY2011 · HL

Translational Studies in Heart Failure Gene Therapy

$847,498
Charles R Bridges · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · HL

Translational Studies in Heart Failure Gene Therapy

$847,498
Charles R Bridges · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL

Translational Studies in Heart Failure Gene Therapy

$847,498
Charles R Bridges · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · HL

Optimizing the allocation of hearts from deceased donors

$847,493
Sommer Elizabeth Gentry · New York University School Of Medicine · R01 · FY2024 · HL

Optimizing the allocation of hearts from deceased donors

$847,492
Sommer Elizabeth Gentry · New York University School Of Medicine · R01 · FY2025 · HL

Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level

$847,474
Anthony Rosenzweig · University Of Michigan At Ann Arbor · R35 · FY2023 · HL

HLD-mediated cholesterol efflux and plaque inflammation in MESA

$847,295
Steven J Shea · Columbia University Health Sciences · R01 · FY2016 · HL

Improving Diagnostic Accuracy for Acute Heart Failure

$847,194
Deepak Gupta · Vanderbilt University Medical Center · R01 · FY2024 · HL

Mechanisms of Purkinje Cell Remodeling

$847,164
Glenn I Fishman · New York University School Of Medicine · R01 · FY2024 · HL

Mechanisms of Purkinje Cell Remodeling

$847,164
Glenn I Fishman · New York University School Of Medicine · R01 · FY2025 · HL

Cardiorenal Genomics for Risk Prediction in African Descent Populations

$846,667
Marguerite R Irvin · University Of Alabama At Birmingham · R35 · FY2025 · HL

Integrative role of Rps6kb1 in pathological cardiac remodeling

$846,536
Zhao Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · HL

Integrative role of Rps6kb1 in pathological cardiac remodeling

$846,536
Zhao Wang · Beckman Research Institute/City Of Hope · R01 · FY2024 · HL

Oxidation-mediated structural degeneration of bioprosthetic heart valves

$846,165
Robert J Levy · Children'S Hosp Of Philadelphia · R01 · FY2018 · HL